Effectiveness and Management of Ponatinib As Second-Line Treatment in Chronic Myeloid Leukemia: an Analysis from the Monitoring Registries of the Italian Medicines Agency (AIFA)
Annals of hematology（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined